Journal Home
Search for

Volume 125, Issue 1, Pages 17-23 (13 March 1998)


View previous. 3 of 35 View next.

Increased susceptibility of the c-Myc overexpressing cell line, SNU-16, to TNF-alpha

In-Chul Parka, Myung-Jin Parkab, Seung-Hoon Leea, Tae-Boo Choeb, Ja-Jun Jangc, Seok-Il HongaCorresponding Author Information

Received 26 June 1997; received in revised form 1 September 1997; accepted 2 October 1997.

Abstract 

Tumor necrosis factor-alpha (TNF-α) is a macrophage-derived multifunctional cytokine that acts as a cytostatic or cytotoxic agent in many tumor cells. However, the molecular mechanisms by which tumor cells become sensitive to the cytotoxic action of TNF-α are not clear. In this study we demonstrated that the cytotoxicity of TNF-α markedly increased in c-Myc overexpressing tumor cells. The stomach cancer cell line, SNU-16, in which c-Myc expression is high due to gene amplification, showed programmed cell death detected by DNA fragmentation and morphological changes. An antisense c-myc S-oligonucleotide specifically inhibited the TNF-α-induced apoptosis of SNU-16 cells, provided that the oligonucleotide was added 4 h prior to TNF-α treatment. Western immunoblot analysis of p53 and Bax showed that in this cell line, TNF-α increased the level of these proteins in a time-dependent manner and that this effect lasted for 12 h. Taken together these data indicate that the deregulation of c-Myc plays an important role in sensitizing tumor cells to TNF-α. Furthermore, TNF-α-induced apoptosis in the SNU-16 cell line showed increased expression of p53 and Bax protein levels following TNF-α treatment. Therefore, we suggest that TNF-α-induced apoptosis, which is cytotoxic to tumor cells, is coupled with a p53 and Bax apoptotic pathway.

a Laboratory of Cell Biology, Korea Cancer Center Hospital, 215-4 Gongneung-dong, Nowon-ku, Seoul 139-240, South Korea

b Department of Microbiological Engineering, Kon-Kuk University, Seoul, South Korea

c Department of Pathology, College of Medicine, Seoul National University, Seoul, South Korea

Corresponding Author InformationCorresponding author. Tel.: +82 2 9701260; fax: +82 2 9782005.

PII: S0304-3835(97)00450-3


View previous. 3 of 35 View next.